Roche Gets Priority Review for Enspryng; Announces Sequencing Platform
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
Roche has received priority review for Enspryng and announced a sequencing platform. The company has also launched a product called AXELIOS 1, and there are reports of a deal related to Excalipoint. Additionally, Roche has announced positive phase III results, although the specific product or treatment associated with these results is not clear.